Jane Street Group, LLC Viking Therapeutics, Inc. Transaction History

Jane Street Group, LLC

$88.2 Billion
Q2 2024

A detailed history of Jane Street Group, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 383,332 shares of VKTX stock, worth $25.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

383,332

Previous 347,088 10.44%

Holding current value

$25.3 Million

Previous $28.5 Million 28.6%

% of portfolio

0.02%

Previous 0.04%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$47.39 - $80.2 $1.72 Million - $2.91 Million	36,244 Added 10.44%	383,332 $20.3 Million
Q1 2024 May 15, 2024	SELL	$17.4 - $94.5 $54,844 - $297,864	-3,152 Reduced 0.9%	347,088 $28.5 Million
Q4 2023 Feb 14, 2024	BUY	$9.24 - $19.64 $898,506 - $1.91 Million	97,241 Added 38.44%	350,240 $6.52 Million
Q3 2023 Nov 14, 2023	SELL	$10.92 - $16.0 $3.16 Million - $4.63 Million	-289,071 Reduced 53.33%	252,999 $2.8 Million
Q2 2023 Aug 14, 2023	BUY	$14.84 - $24.79 $2.74 Million - $4.57 Million	184,425 Added 51.57%	542,070 $8.79 Million
Q1 2023 May 15, 2023	BUY	$8.08 - $17.33 $2.42 Million - $5.2 Million	299,830 Added 518.6%	357,645 $5.95 Million
Q4 2022 Feb 14, 2023	BUY	$2.72 - $9.4 $122,149 - $422,135	44,908 Added 347.94%	57,815 $543,000
Q3 2022 Nov 14, 2022	SELL	$2.55 - $3.89 $40,121 - $61,205	-15,734 Reduced 54.94%	12,907 $36,000
Q2 2022 Aug 16, 2022	SELL	$2.11 - $3.15 $25,777 - $38,483	-12,217 Reduced 29.9%	28,641 $83,000
Q1 2022 May 17, 2022	BUY	$3.0 - $4.88 $54,675 - $88,938	18,225 Added 80.52%	40,858 $123,000
Q4 2021 Feb 15, 2022	SELL	$4.6 - $6.72 $36,358 - $53,114	-7,904 Reduced 25.88%	22,633 $104,000
Q3 2021 Nov 16, 2021	SELL	$5.58 - $7.04 $242,194 - $305,564	-43,404 Reduced 58.7%	30,537 $192,000
Q1 2021 May 18, 2021	BUY	$5.74 - $9.67 $240,982 - $405,975	41,983 Added 131.37%	73,941 $467,000
Q4 2020 Feb 17, 2021	SELL	$5.3 - $6.71 $18,724 - $23,706	-3,533 Reduced 9.95%	31,958 $180,000
Q3 2020 Nov 17, 2020	BUY	$5.73 - $8.11 $134,672 - $190,609	23,503 Added 196.05%	35,491 $207,000
Q2 2020 Aug 17, 2020	SELL	$4.35 - $8.08 $8,556 - $15,893	-1,967 Reduced 14.1%	11,988 $86,000
Q1 2020 May 15, 2020	BUY	$3.45 - $7.95 $8,010 - $18,459	2,322 Added 19.96%	13,955 $65,000
Q4 2019 Feb 14, 2020	SELL	$6.38 - $8.73 $77,695 - $106,313	-12,178 Reduced 51.14%	11,633 $93,000
Q3 2019 Nov 14, 2019	BUY	$6.55 - $8.6 $1,873 - $2,459	286 Added 1.22%	23,811 $164,000
Q2 2019 Aug 15, 2019	SELL	$7.67 - $10.63 $965,361 - $1.34 Million	-125,862 Reduced 84.25%	23,525 $196,000
Q1 2019 May 16, 2019	BUY	$7.58 - $9.94 $161,620 - $211,940	21,322 Added 16.65%	149,387 $1.49 Million
Q3 2018 Nov 14, 2018	BUY	$9.7 - $19.65 $1.24 Million - $2.52 Million	128,065 New	128,065 $2.23 Million

Others Institutions Holding VKTX

# of Institutions

478

Shares Held

66.1M

Call Options Held

6.24M

Put Options Held

3.01M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $5.05B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Viking Therapeutics, Inc. Transaction History